By Kaplan-Meier analysis, only DNMT3A overexpression was associated with longer overall survival (OS) and leukemia-free survival (LFS) in whole-cohort AML (P=0.001 and 0.003, respectively, Figure 4). This evidence concerns the gene DNMT3A and leukemia.